These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 6425078

  • 1. [Pharmacological action on the thromboxane and prostacyclin balance in the body].
    Lakin KM, Makarov VA, Novikova NV, Tret'iak VM, Rukazenkov IuE.
    Farmakol Toksikol; 1984; 47(2):67-79. PubMed ID: 6425078
    [No Abstract] [Full Text] [Related]

  • 2. [Suppression of platelet aggregation as a result of two-component inhibition of a polyenzyme system of thromboxane synthesis].
    Varfolomeev SD, Lakin KM, Mevkh AT, Novikova NV, Rukazenkov IuZ.
    Dokl Akad Nauk SSSR; 1985; 282(1):194-6. PubMed ID: 3928305
    [No Abstract] [Full Text] [Related]

  • 3. Potentiation by dazoxiben, a thromboxane synthetase inhibitor, of platelet aggregation inhibitory activity of a thromboxane receptor antagonist and of prostacyclin.
    Bertele V, De Gaetano G.
    Eur J Pharmacol; 1982 Dec 03; 85(3-4):331-3. PubMed ID: 6295787
    [Abstract] [Full Text] [Related]

  • 4. Imidazo[1,5-a]pyridines: a new class of thromboxane A2 synthetase inhibitors.
    Ford NF, Browne LJ, Campbell T, Gemenden C, Goldstein R, Gude C, Wasley JW.
    J Med Chem; 1985 Feb 03; 28(2):164-70. PubMed ID: 3918169
    [Abstract] [Full Text] [Related]

  • 5. Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin.
    Moncada S, Vane JR.
    Pharmacol Rev; 1978 Sep 03; 30(3):293-331. PubMed ID: 116251
    [No Abstract] [Full Text] [Related]

  • 6. New trends in thromboxane and prostacyclin modulators.
    Dogné JM, de Leval X, Delarge J, David JL, Masereel B.
    Curr Med Chem; 2000 Jun 03; 7(6):609-28. PubMed ID: 10702629
    [Abstract] [Full Text] [Related]

  • 7. The prostacyclin--thromboxane A2 balance: pathophysiological and therapeutic implications.
    Bunting S, Moncada S, Vane JR.
    Br Med Bull; 1983 Jul 03; 39(3):271-6. PubMed ID: 6354352
    [No Abstract] [Full Text] [Related]

  • 8. Modulation of human platelet function by prostacyclin and thromboxane A2.
    Gorman RR.
    Fed Proc; 1979 Jan 03; 38(1):83-8. PubMed ID: 215465
    [No Abstract] [Full Text] [Related]

  • 9. Platelet function and biosynthesis of prostacyclin and thromboxane A2 in whole blood after aspirin administration in human subjects.
    Mehta JL, Mehta P, Lopez L, Ostrowski N, Aguila E.
    J Am Coll Cardiol; 1984 Oct 03; 4(4):806-11. PubMed ID: 6384329
    [Abstract] [Full Text] [Related]

  • 10. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides.
    Mehta J, Mehta P, Lawson DL, Ostrowski N, Brigmon L.
    J Lab Clin Med; 1985 Sep 03; 106(3):246-52. PubMed ID: 3928780
    [Abstract] [Full Text] [Related]

  • 11. The biochemical pharmacology of thromboxane synthase inhibition in man.
    FitzGerald GA, Reilly IA, Pedersen AK.
    Circulation; 1985 Dec 03; 72(6):1194-201. PubMed ID: 3905048
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of prostacyclin and platelet thromboxane A2 after low-dose aspirin.
    Preston FE, Whipps S, Jackson CA, French AJ, Wyld PJ, Stoddard CJ.
    N Engl J Med; 1981 Jan 08; 304(2):76-9. PubMed ID: 7003384
    [Abstract] [Full Text] [Related]

  • 13. Aspirin, thromboxane, and prostacyclin in rats: A dilemma resolved?
    Livio M, Villa S, de Gaetano G.
    Lancet; 1978 Jun 17; 1(8077):1307. PubMed ID: 78064
    [No Abstract] [Full Text] [Related]

  • 14. Inhibitors of prostaglandin, prostacyclin, and thromboxane synthesis.
    Vane JR.
    Adv Prostaglandin Thromboxane Res; 1978 Jun 17; 4():27-44. PubMed ID: 417572
    [No Abstract] [Full Text] [Related]

  • 15. Platelet rich plasma transforms exogenous prostaglandin endoperoxide H2 into thromboxane A2.
    Fitzpatrick FA, Gorman RR.
    Prostaglandins; 1977 Nov 17; 14(5):881-9. PubMed ID: 594390
    [Abstract] [Full Text] [Related]

  • 16. [Thromboxane A2 antagonist, prostacyclin (PGI2)--its in vivo secretion and action mechanism].
    Okuma M.
    Nihon Rinsho; 1978 Dec 10; 36(12):3830-5. PubMed ID: 372621
    [No Abstract] [Full Text] [Related]

  • 17. Redirecting thromboxane A2 and prostacyclin biosyntheses from thrombotic to antithrombotic property by an Enzymelink.
    Ruan DT, Lu R, Ruan KH.
    Future Med Chem; 2021 May 10; 13(9):765-768. PubMed ID: 33759567
    [No Abstract] [Full Text] [Related]

  • 18. Evidence that prostaglandin endoperoxides can induce platelet aggregation in the absence of thromboxane A2 production.
    Hornby EJ, Skidmore IF.
    Biochem Pharmacol; 1982 Mar 15; 31(6):1158-60. PubMed ID: 7200773
    [No Abstract] [Full Text] [Related]

  • 19. Inhibition of thromboxane A2 biosynthesis in human platelets by burimamide.
    Allan G, Eakins KE, Kulkarni PS, Levi R.
    Br J Pharmacol; 1980 Mar 15; 71(1):157-64. PubMed ID: 6781572
    [Abstract] [Full Text] [Related]

  • 20. Endogenous biosynthesis of prostaglandin I2 and thromboxane A2 by isolated rat dental pulp.
    Hirafuji M, Ogura Y.
    Biochem Pharmacol; 1983 Oct 01; 32(19):2983-5. PubMed ID: 6354192
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.